Drug intelligence / Profile preview

gentiopicrin

Development stage
Preclinical
Modality
Nanoparticles → Drug Delivery Systems, Small Molecules
Administration
Topical
01

Overview

Gentiopicrin (also known as gentiopicroside) is a secoiridoid glycoside primarily derived from plants of the *Gentiana* genus, such as *Gentiana lutea*. It is recognized for its diverse pharmacological activities, including anti-inflammatory, analgesic, hepatoprotective, and anti-proliferative effects. In the context of psoriasis research, gentiopicrin has been shown to inhibit the excessive proliferation and migration of keratinocytes while inducing their apoptosis. It further modulates the immune response by downregulating the expression of key pro-inflammatory mediators, including IL-17A and CXCL2. To overcome its poor skin permeability, researchers have investigated advanced delivery systems like chitosan-coated liposomal nanoparticles (CS@Gen) for topical application, which have demonstrated efficacy in reducing epidermal thickness and scaling in animal models.

Other names
gentiopicroside
02

Targets

PPARA (Peroxisome proliferator-activated receptor alpha)NF-κBCYCS (Cytochrome c)CASP3 (Caspase-3)HIF1A (Hypoxia-inducible factor 1-alpha)

Beyond the preview

Go deeper on gentiopicrin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on gentiopicrin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call